NASDAQ: KLTO
Klotho Neurosciences Inc Stock Ownership - Who owns Klotho Neurosciences?

Insider buying vs selling

Have Klotho Neurosciences Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when KLTO insiders and whales buy or sell their stock.

KLTO Shareholders

What type of owners hold Klotho Neurosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Joseph Sinkule6.68%4,846,700$2.06MInsider
Redwoods Capital LLC4.29%3,115,000$1.32MInsider
Chardan Capital Markets LLC1.77%1,284,364$544.57kInsider
Jeff Leblanc1.27%920,342$390.23kInsider
Samuel M. Zentman1.02%736,440$312.25kInsider
Vanguard Group Inc0.81%588,342$249.46kInstitution
Shalom Hirschman0.77%558,873$236.96kInsider
Geode Capital Management LLC0.45%323,927$137.35kInstitution
Northern Trust Corp0.30%218,785$92.76kInstitution
State Street Corp0.27%196,400$83.27kInstitution

1 of 3

KLTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KLTO2.52%16.11%
PLUR0.04%99.96%Net Buying
LEXX7.73%3.68%Net Buying
INTS4.93%3.48%Net Buying
NRXS7.60%23.88%Net Selling

Klotho Neurosciences Stock Ownership FAQ

Who owns Klotho Neurosciences?

Klotho Neurosciences (NASDAQ: KLTO) is owned by 2.52% institutional shareholders, 16.11% Klotho Neurosciences insiders, and 81.38% retail investors. Joseph Sinkule is the largest individual Klotho Neurosciences shareholder, owning 4.85M shares representing 6.68% of the company. Joseph Sinkule's Klotho Neurosciences shares are currently valued at $1.94M.

If you're new to stock investing, here's how to buy Klotho Neurosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.